CERRITOS, Calif.

NORWOOD, Mass.

(RTTNews) - InSilico Medicine Cayman TopCo.

Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity NewsletterInsilico Medicine achieved an R&D collaboration with Servier valued at up to US$888 million, focused on discovering and developing innovative oncology therapies, by combining Insilico's AI-driven drug discovery platforms with Servier's global expertise in cancer drug development.

(RTTNews) - Insilico Medicine announced that it has entered into a multi-year research and development (R&D) collaboration with Servier, an independent international pharmaceutical company governed by a foundation.

It might take a while longer, but Pfizer is on the path to recovery.